Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial

P. Geusens*, D.L. Kendler, A. Fahrleitner-Pammer, P. Lopez-Romero, F. Marin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)646-654
Number of pages9
JournalCalcified Tissue International
Volume106
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • alendronate
  • back-pain
  • bisphosphonates
  • deformities
  • men
  • mortality
  • number
  • older women
  • osteoporosis
  • risedronate
  • risk
  • severity
  • spine
  • teriparatide
  • vertebral fractures
  • Risedronate
  • MORTALITY
  • Vertebral fractures
  • Spine
  • DEFORMITIES
  • Bisphosphonates
  • Osteoporosis
  • BACK-PAIN
  • NUMBER
  • RISK
  • ALENDRONATE
  • MEN
  • OLDER WOMEN
  • Teriparatide
  • SEVERITY

Cite this